Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | SHR1501 |
| Synonyms | |
| Therapy Description |
SHR1501 is a fusion protein comprised of IL-15 linked to the sushi domain of the IL-15 receptor alpha, which may activate an antitumor immune response, thereby leading to enhanced killing and reduced proliferation of tumor cells (NCI Thesaurus). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| SHR1501 | SHR 1501|SHR-1501 | SHR1501 is a fusion protein comprised of IL-15 linked to the sushi domain of the IL-15 receptor alpha, which may activate an antitumor immune response, thereby leading to enhanced killing and reduced proliferation of tumor cells (NCI Thesaurus). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|